Fiche centre
Charité
Berlin — Germany
Essais liés3clinical trials
VilleBerlinlocalisation
PaysGermanylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05039099
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Dapagliflozin 10 mg/day (oral) | Maladie rénale chronique | Phase 3 | NCT05374291 | The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD | ACTIVE_NOT_RECRUITING |
| AP-101 | Sclérose latérale amyotrophique | Phase 2 | NCT05039099 | A Study to Evaluate, Safety, Tolerability, and PK of AP-101 in Participants With ALS | COMPLETED |
| NECVAX-NEO1 | Cancer | Phase 1 | NCT06631079 | Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors | ACTIVE_NOT_RECRUITING |